Arvind Ltd. Launches Anti-Viral Fabrics Under ‘Intellifabrix’ Brand

New Products and Innovation

Arvind Ltd. Launches Anti-Viral Fabrics Under ‘Intellifabrix’ Brand

Arvind Ltd. partners with Swiss Textile Innovator HeiQ to introduce HeiQ Viroblock technology in India. Arvind will offer shirting and suiting fabrics, readymade garments and face masks using this technology. Arvind Limited, India’s leading textile-to-retail conglomerate has launched anti-viral textile technology for the first time in India under its brand “Intellifabrix”. Arvind has partnered with Swiss textile innovation leader HeiQ Materials AG in association with Taiwanese specialty chemical major M/S Jintex Corporation to introduce this revolutionary anti-virus technology in India. Research shows that viruses and bacteria can remain active on textile surfaces for up to two days. Garments treated with HeiQ Viroblock actively inhibit viruses and kill them upon contact, helping to minimise the potential for re-transmission of pathogens through clothing. Announcing the launch of the anti-viral fabrics under Intellifabrix, Kulin Lalbhai, Executive Director, Arvind Limited, says, “In these unprecedented times, we are committed to keep our customers safe and that is why we have tied up with HeiQ to bring its revolutionary Viroblock technology to India. We are excited with this partnership and in a very short period of time we will introduce into the Indian market fabrics that will provide best-in-class viral protection and are fashionable at the same time.” HeiQ Viroblock is one of the most advanced global anti-viral products created by HeiQ, a Swiss textile innovator. HeiQ Viroblock significantly enhances the anti-viral log reduction and reduces viral infectivity by 99.99% and is one of the first textile technologies in the world to claim such efficacy on SARS-CoV-2. HeiQ Viroblock has been designed to stay active on treated garments for 30 gentle domestic washes, ensuring safety for the consumer that lasts for a good part of the garment’s life. Talking about the partnership Carlo Centonze, CEO, HeiQ Group said, "HeiQ Viroblock is a special combination of our advanced silver and vesicle technology that has been proven effective against the human coronavirus 229E & SARS-CoV-2, causing Covid-19, with 99.99% reduction of virus in 30 minutes. It is a safe, hypoallergenic and patent pending technology. We are pleased to partner with Arvind in India to offer this technology across their range of products”